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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S446reduce chondrogenic capacity of sMPCs. Taken together, these ﬁndings
raise interesting insight into the inﬂammatory inﬂuences on OA
pathogenesis and cartilage regeneration.
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MESENCHYMAL STEM CELLS IN SYNOVIAL FLUID INCREASE AFTER
SYNOVIAL BIOPSY
M. Ojima y, I. Sekiya z, K. Tsuji x, T. Muneta y. y Joint Surgery and Sports
Med., Tokyo Med. and Dental Univ., Tokyo, Japan; zCtr. for Stem Cell and
Regenerative Med., Tokyo Med. and Dental Univ., Tokyo, Japan; xDept. of
Cartilage Regeneration, Tokyo Med. and Dental Univ., Tokyo, Japan
Purpose: We previously reported that the number of mesenchymal
stem cells (MSCs) in synovial ﬂuid was higher in knees with anterior
cruciate ligament insufﬁciency and osteoarthritis than in normal knees.
MSCs in synovial ﬂuid were similar to synovium MSCs from the view-
point of morphological and gene proﬁles. In this study, we investigated
whether the number of MSCs in synovial ﬂuid increased after synovial
biopsy.
Methods: The studywas approved by an institutional review board, and
informed consents were obtained from all study subjects. We obtained
synovial ﬂuid from the knee joints of 9 patients, who underwent
transplantation of synovial MSCs for cartilage injury, before and 2
weeks after harvest of 0.5g of synovium. We expanded the nucleated
cells in synovial ﬂuid for 2 weeks and counted the number of cell col-
onies stained with crystal violet. We also examined chon-
drogenic,adipogenic and osteogenic differentiation of these cells. For
gene proﬁle,28,000 genes were analyzed with microarray, and gene
expressions were conﬁrmed with quantitative real time-PCR.
Results: The total cell number obtained from 1ml of synovial ﬂuid
before synovial biopsy was 142  192 and that 2 weeks after synovial
biopsy was 238  196. Total cell number obtained from 1ml of synovial
ﬂuid before synovial biopsy was (95129) 103 and that 2 weeks after
synovial biopsy was (241  258) 103.Both the number of cell colonies
and the number of cells signiﬁcantly increased after synovial biopsy (p
< 0.05). The colony forming cells differentiated into chondrocytes,adipocytes, and osteoblasts. The expressions of subset of genes altered
in MSCs derived from synovial ﬂuid obtained before and after synovial
biopsy.
Conclusion:MSCs in synovial ﬂuid increased in the knee after synovial
biopsy.
This was possibly due to inﬂammation and the repair process after
synovial biopsy. It would be an interesting future topic to examine how
many MSCs in synovial ﬂuid contributed to the repair of the synovium.
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EXPRESSION ANALYSIS OF OSTEOARTHRITIS ASSOCIATED GENES IN
MESENCHYMAL STEM CELLS DIFFERENTIATING INTO JOINT-
ASSOCIATED CELLS
E.L. Rogers, L.N. Reynard, K. Rennie, K. Rankin, J. Loughlin. Newcastle
Univ., Newcastle upon Tyne, United Kingdom
Purpose: Historically recognised as a primary cartilage pathology,
osteoarthritis (OA) is now understood to affect all joint-associated tis-
sues. It has been hypothesised that gene dysregulation during joint
formation may lead to the abnormal development and maintenance, or
repair, of joint-associated tissues, thus conferring OA susceptibility.
Genome wide association studies (GWAS) have identiﬁed multiple OA-
associated genes, some of which have been shown to function during
cell development and differentiation. However, many genes identiﬁed
by such studies remain to be characterised. The ﬁrst aim of this study
was therefore to establish if a panel of OA-associated genes are
expressed in mesenchymal stem cells (MSCs) that have undergone
directed differentiation into joint-associated cells, and whether differ-
ential expression occurs in MSCs from OA patients. Additionally, this
study sought to analyse the differentiation potential of OA patient-
derived MSCs compared to MSCs from controls.
Methods: MSCs were extracted from the femoral head and from bone
marrow aspirates of OA patients undergoing hip or knee arthroplasty
respectively. Control MSCs were obtained from both neck of femur
(NOF) fracture patients and young, healthy individuals. MSCs were
subsequently differentiated using transwell culturing into osteoblasts,
chondrocytes and adipocytes over a 14 day period, and RNA was
extracted from cells harvested on days 0, 3 and 14 of differentiation. The
differentiation potential of MSCs was analysed by histological staining
and by quantitative PCR (qPCR) of lineage-speciﬁc genes. A selection of
13 genes within OA-susceptibility loci, as identiﬁed by GWAS, were
studied during differentiation by qPCR.
Results: Osteogenic potential was preserved in OA patient-derived MSCs
when compared to controls, as determined by Fast blue RR alkaline
phosphatase staining and qPCR of osteogenic marker genes. Adipogenic
differentiation, assessedby PPARg induction,was found to be less efﬁcient
inOApatientMSCs,withdecreased inductionof PPARgwhencompared to
controls. qPCRof cDNA from chondrogenesis experiments revealed a large
degree of inter-individual variability when analysing chondrogenic-spe-
ciﬁc genes, meaning it was not possible to deduce the chondrogenic efﬁ-
ciency in OA patient MSCs compared to controls. Of the genes contained
within OA-associated regions, MCF2L was the only gene for which
expression was not detected in any lineage during differentiation. The
remaining 12 genes were expressed in a dynamic manner, with a large
degree of inter-individual variability. Differential expression of individual
genes was not apparent when comparing the OA and control groups.
Conclusions: Differentiation potential of OA-derived MSCs could be
impaired during chondrogenesis and adipogenesis, while osteogenic
differentiation appears to be preserved. To date, there are few published
reports on the efﬁciency of OA-MSC chondrogenesis using transwell
culture, which is believed to be a more faithful recapitulation of
chondrogenesis when compared to other techniques. This may there-
fore have bearings on the success of autologous stem cell treatments for
osteoarthritic patients, with further studies utilising more samples
required to uphold this ﬁnding. MCF2L is not expressed in MSCs during
in vitro differentiation into joint associated cells, which would suggest
any potential effects of this gene on the OA joint is asserted later in
development, or in the mature joint. All other genes within the OA-
associated regions were expressed in a variety of patterns, indicating a
possible function in joint development. However, no speciﬁc difference
in expression was noted when comparing OA and control gene
expression, meaning it was not possible to deduce speciﬁc genes of
interest for future study. Despite this, the dynamic of expression of OA-
associated genes in differentiating MSCs supports the possibility of a
developmental aetiology of OA.
